The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
Open accessAbstract
The renin-angiotensin system (RAS) is a key regulator of vascular tone and blood pressure. In addition, angiotensin II also has a number of cellular effects that may contribute to disease pathogenesis. Using Agtr1a(-/-) mice, which lack AT(1A) receptors for angiotensin II, we have identified a novel function of the RAS to modulate the immune system. We find that angiotensin II, acting through type 1 (AT(1)) receptors on immune cells, triggers the proliferation of splenic lymphocytes. These actions contribute to the vigor of cellular alloimmune responses. Within lymphoid organs, sufficient components of the RAS are present to activate AT(1) receptors during an immune response, promoting cell growth. These actions require activation of calcineurin phosphatase. In an in vivo model of cardiac transplantation, the absence of AT(1) signaling accentuates the immunosuppressive effects of the calcineurin inhibitor cyclosporine. We conclude that inhibition of AT(1) receptor signaling should be useful as an anti-inflammatory and immunosuppressive therapy. Furthermore, the actions of the RAS to promote lymphocyte activation may contribute to inflammation that characterizes a number of diseases of the heart and the vascular system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function
Rao, A., Luo, C., & Hogan, P. G. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.707 · Cited by 2,603
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
The mechanism of action of cyclosporin A and FK506
Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127
Signal transduction by lymphocyte antigen receptors
Weiss, A., & Littman, D. R. (1994) · Cell · doi:10.1016/0092-8674(94)90334-4 · Cited by 2,089
Angiotensin II receptors and angiotensin II receptor antagonists.
Timmermans, P. B., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. A., & Smith, R. D. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00446-6 · Cited by 1,853
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
Clipstone, N. A., & Crabtree, G. R. (1992) · Nature · doi:10.1038/357695a0 · Cited by 1,637
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
Harding, M. W., Galat, A., Uehling, D. E., & Schreiber, S. L. (1989) · Nature · doi:10.1038/341758a0 · Cited by 1,396
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
Mach, F., Schönbeck, U., Sukhova, G. K., Atkinson, E., & Libby, P. (1998) · Nature · doi:10.1038/28204 · Cited by 910
Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
Marrero, M. B., Schieffer, B., Paxton, W. G., Heerdt, L., Berk, B. C., Delafontaine, P., & Bernstein, K. E. (1995) · Nature · doi:10.1038/375247a0 · Cited by 745
Regulation of blood pressure by the type 1A angiotensin II receptor gene.
Ito, M., Oliverio, M. I., Mannon, P. J., Best, C. F., Maeda, N., Smithies, O., & Coffman, T. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3521 · Cited by 616
Self-citationCosterousse, O., Allegrini, J., Lopez, M., & Alhenc-Gelas, F. (1993) · Biochemical Journal · doi:10.1042/bj2900033 · Cited by 507
Prevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition
Sussman, M. A., Lim, H. W., Gude, N., Taigen, T., Olson, E. N., Robbins, J., Colbert, M. C., Gualberto, A., Wieczorek, D. F., & Molkentin, J. D. (1998) · Science · doi:10.1126/science.281.5383.1690 · Cited by 461
Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease
Diet, F., Pratt, R. E., Berry, G. J., Momose, N., Gibbons, G. H., & Dzau, V. J. (1996) · Circulation · doi:10.1161/01.cir.94.11.2756 · Cited by 426
Isolation of the Cyclosporin-Sensitive T Cell Transcription Factor NFATp
McCaffrey, P. G., Luo, C., Kerppola, T. K., Jain, J., Badalian, T. M., Ho, A. M., Burgeon, E., Lane, W. S., Lambert, J. N., Curran, T., et al. (1993) · Science · doi:10.1126/science.8235597 · Cited by 412
Sasamura, H., Hein, L., Krieger, J. E., Pratt, R. E., Kobilka, B. K., & Dzau, V. J. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80983-0 · Cited by 307
Angiotensin Receptors and Their Therapeutic Implications
Greindling, K. K., Lassegue, B., & Alexander, R. W. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001433 · Cited by 262
JAK/STAT signaling by cytokine receptors
Liu, K. D., Gaffen, S. L., & Goldsmith, M. A. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80165-9 · Cited by 234
Differential expression of angiotensin receptor 1A and 1B in mouse
Burson, J. M., Aguilera, G., Gross, K. W., & Sigmund, C. D. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.2.e260 · Cited by 227
Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells
Owens, G. K. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.257.6.h1755 · Cited by 217
Calcineurin mediates inhibition by FK506 and cyclosporin of recovery from α-factor arrest in yeast
Poor, F., Parent, S. A., Morin, N., Dahl, A. M., Ramadan, N., Chrebet, G., Bostian, K. A., & Nielsen, J. B. (1992) · Nature · doi:10.1038/360682a0 · Cited by 192
Synthesis, transfer, and phosphorylation of phosphoinositides in cardiac membranes
Wolf, R. A. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.259.6.c987 · Cited by 179
Llorens-Cortes, C., Greenberg, B., Huang, H., & Corvol, P. (1994) · Hypertension · doi:10.1161/01.hyp.24.5.538 · Cited by 168
Silverstein, E., Pertschuk, L. P., & Friedland, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.12.6646 · Cited by 166
Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice
Hisada, Y., Sugaya, T., Yamanouchi, M., Uchida, H., Fujimura, H., Sakurai, H., Fukamizu, A., & Murakami, K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci2454 · Cited by 152
Ray, P. E., Bruggeman, L. A., Horikoshi, S., Aguilera, G., & Klotman, P. E. (1994) · Kidney International · doi:10.1038/ki.1994.21 · Cited by 120
Amuchastegui, S., Azzollini, N., Mister, M., Pezzotta, A., Perico, N., & Remuzzi, G. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9101948 · Cited by 118
Angiotensin II Increases Monocyte Binding to Endothelial Cells
Kim, J. A., Berliner, J. A., & Nadler, J. L. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1441 · Cited by 117
Identification of a human neutrophil angiotension II-generating protease as cathepsin G.
Tonnesen, M. G., Klempner, M. S., Austen, K. F., & Wintroub, B. U. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110437 · Cited by 106
Angiotensin II signal transduction and the mitogen-activated protein kinase pathway
Duff, J. L., Marrero, M. B., Paxton, W. G., Schieffer, B., Bernstein, K. E., & Berk, B. C. (1995) · Cardiovascular Research · doi:10.1016/s0008-6363(95)00088-7 · Cited by 94
Leukocytes synthesize angiotensinogen.
Gómez, R. A., Norling, L. L., Wilfong, N., Isakson, P. C., Lynch, K. R., Hock, R. A., & Quesenberry, P. J. (1993) · Hypertension · doi:10.1161/01.hyp.21.4.470 · Cited by 93
Benediktsson, H., Chea, R., Davidoff, A. W., & Paul, L. C. (1996) · Transplantation · doi:10.1097/00007890-199612150-00018 · Cited by 88
Binding Sites for Angiotensin II in Human Mononuclear Leucocytes1
Shimada, K., & Yazaki, Y. (1978) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a132183 · Cited by 79
Effect of angiotensin II on macrophage functions.
Fóris, G., Dezsö, B., MEDGYESI, G. A., & Füst, G. (1983) · PubMed · Cited by 73
Furukawa, Y., Matsumori, A., Hirozane, T., & Sasayama, S. (1996) · Circulation · doi:10.1161/01.cir.93.2.333 · Cited by 73
An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis.
Tanaka, A., Matsumori, A., Wang, W., & Sasayama, S. (1994) · Circulation · doi:10.1161/01.cir.90.4.2051 · Cited by 60
Evidence for the presence of angiotensins in normal, unstimulated alveolar macrophages and monocytes
Dezsö, B., Jacobsen, J., & Poulsen, K. (1989) · Journal of Hypertension · doi:10.1097/00004872-198901000-00002 · Cited by 59
Candesartan cilexetil reduces chronic renal allograft injury in Fisher → Lewis rats
Mackenzie, H. S., Ziai, F., Nagano, H., Azuma, H., Troy, J. L., Rennke, H. G., Tilney, N. L., & Brenner, B. M. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715066-00005 · Cited by 54
Kunertradek, J., Stepien, H., Komorowski, J., & Pawlikowski, M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1147 · Cited by 37
Characterization of angiotensin II receptor subtypes in the rat spleen
Tsutsumi, K., Strömberg, C., & Saavedra, J. M. (1992) · Peptides · doi:10.1016/0196-9781(92)90111-f · Cited by 31
Chemotactic response of splenic mononuclear cells to angiotensin II in murine schistosomiasis.
Weinstock, J. V., & Kassab, J. T. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.2020 · Cited by 29
Mouse angiotensin receptor genes Agtrla and Agtr1b map to Chromosomes 13 and 3
MacTaggart, T. E., Ito, M., Smithies, O., & John, S. W. M. (1997) · Mammalian Genome · doi:10.1007/s003359900419 · Cited by 25
Self-citation
Cited by
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Calcineurin: Form and Function
Rusnak, F., & Mertz, P. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1483 · Cited by 1,373
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
Dragun, D., Müller, D. N., Bräsen, J. H., Fritsche, L., Nieminen-Kelhä, M., Dechend, R., Kintscher, U., Rudolph, B., Hoebeke, J., Eckert, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa035717 · Cited by 868
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
Crowley, S. D., Gurley, S. B., Herrera, M. J., Ruiz, P., Griffiths, R., Kumar, A. P., Kim, H.-S., Smithies, O., Le, T. H., & Coffman, T. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605545103 · Cited by 714
Self-citation
Metadata
- Authors
- Nataraj, C., Oliverio, M. I., Mannon, R. B., Mannon, P. J., Audoly, L. P., Amuchastegui, C. S., Ruiz, P., Smithies, O., & Coffman, T. M.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-12-15
- Volume
- 104
- Issue
- 12
- Pages
- 1693-1701
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2095434115
- Cited by
- 308
- References
- 42
- FWCI
- 10.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.